Octagon Capital Advisors’s Verastem VSTM Stock Holding History

Octagon Capital Advisors’s Portfolio VSTM Stock Details VSTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-1,720,000	Closed	-$10.4M	–	37
2025 Q1	$10.4M	Buy	+1,720,000	New	+$10.5M	2.01%	22

Other funds holding VSTM

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JGC

J. Goldman & Co New York $3.44B AUM 33.8% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $249M AUM 80.12% 1-Year Est. Return

Octagon Capital Advisors's VSTM Position: Q2 2025 in Review

Octagon Capital Advisors sold out of Verastem (VSTM) in Q2 2025, closing a stake of 1,720,000 shares — an estimated $10.4M sold.

Octagon Capital Advisors first reported a position in VSTM in Q1 2025 and held it in 1 quarter. The position peaked at $10.4M in Q1 2025. 109 funds tracked by Wall St. Rank hold VSTM as of Q2 2025.

Octagon Capital Advisors reported no remaining Verastem position as of Q2 2025 after selling out during the quarter.
Octagon Capital Advisors sold 1,720,000 Verastem shares in Q2 2025, an estimated $10.4M.
Octagon Capital Advisors first reported a position in Verastem in Q1 2025 and held it in 1 quarter.
Octagon Capital Advisors's Verastem position peaked at $10.4M in Q1 2025.
109 funds tracked by Wall St. Rank held Verastem as of Q2 2025.

Based on Octagon Capital Advisors's 13F filing for Q2 2025, filed 14 Aug 2025.